ArticleiScience2026

Dasatinib resensitizes BRAF/MEK inhibitor efficacy in patient-derived xenografts from patients with progression on BRAF/MEK inhibitor treatment.

Vito W Rebecca et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.